Pioneers of the Future
BiosYnth's technology is a marvel of versatility, a power adaptable to the multiple challenges
posed by various diseases. Our technological processes are as flexible as they are innovative,
allowing us to tailor our approaches to meet the specific needs of each health challenge
we face. It's like possessing a single masterfully made rifle, but having the ability to
swap out the bayonet as needed, ensuring we're always precisely equipped to target and
defeat the specific adversities of each disease. This adaptability ensures that our technology
remains at the cutting edge, constantly optimized for the development of life-saving
solutions in the fight against infectious diseases.
Since then, the BiosYnth Team has
been discovering new technologies with passion and creativity for the continuous
improvement of vaccines. In this landscape, BiosYnth is currently developing two main
Technological Platforms that contribute to opening new paths in the Field of Vaccinology:
- 3rd Generation Glycoconjugates
- Nanostructured Vector System for Bacterial and Viral Antigens
Use of CRM197 and TT as T Helper cell-dependent carriers (3rd generation)
Characterized by an immediate activity of enhancing T Helper cells for the conformational epitopes of key antigens
